The incidence of serious complications after selective laser trabeculoplasty
1Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Related Experiment Videos
View abstract on PubMed
Summary
Selective laser trabeculoplasty (SLT) is a safe glaucoma treatment with a low incidence of serious complications. Out of 6081 treatments, only one case of permanent vision deterioration occurred, supporting its use as a first-line therapy.
Area of Science:
- Ophthalmology
- Glaucoma Management
- Laser Therapy
Background:
- Selective laser trabeculoplasty (SLT) is a common procedure for managing ocular hypertension and open-angle glaucoma.
- Evaluating the safety profile of SLT is crucial for clinical decision-making and patient counseling.
Purpose of the Study:
- To determine the incidence of serious complications following selective laser trabeculoplasty (SLT).
- To assess the safety of SLT as a potential first-line treatment option.
Main Methods:
- Retrospective analysis of 6081 SLT procedures performed between 2012 and 2018.
- Data extraction from electronic medical records, including patient demographics, procedure details, and complications.
- Primary outcome measures focused on serious complications such as hyphema, corneal edema, and visual acuity changes.
Main Results:
- The overall incidence of serious complications was very low across 6081 SLT treatments.
- Anterior chamber bleeding occurred in 2/1000 treatments, with hyphema in 0.7/1000.
- Permanent vision deterioration was a rare event, observed in only one patient.
Conclusions:
- Selective laser trabeculoplasty demonstrates a favorable safety profile with minimal serious complications.
- The findings support the use of SLT as a safe and effective first-line treatment for open-angle glaucoma and ocular hypertension.
- Clinicians can confidently discuss the safety of SLT with patients considering this therapeutic option.